Literature DB >> 1575583

Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung.

Y Deguchi1.   

Abstract

The spontaneous increase in the transcription of the transforming growth factor beta (TGF beta) gene in bronchoalveolar mononuclear cells of patients with autoimmune diseases affecting the lung has been shown by northern blot assay and a nuclear run on transcription assay. Transcription of the TGF beta gene in bronchoalveolar mononuclear cells of patients with autoimmune diseases affecting the lung was increased 10 times compared with normal healthy subjects or patients with bronchial asthma as controls. This observation, confirmed by protein data, suggests that TGF beta, a potent mitogen for fibroblasts, may be produced in bronchoalveolar mononuclear cells during an active immune response in such patients and may be involved in autoimmune related changes of the pathophysiology of cytokine networks when the lung is affected, such as in lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575583      PMCID: PMC1004662          DOI: 10.1136/ard.51.3.362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

2.  Age-related changes of heat shock protein gene transcription in human peripheral blood mononuclear cells.

Authors:  Y Deguchi; S Negoro; S Kishimoto
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

3.  Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

Authors:  J C Reed; Y Tsujimoto; J D Alpers; C M Croce; P C Nowell
Journal:  Science       Date:  1987-06-05       Impact factor: 47.728

Review 4.  Cellular immune dysfunction and the pathogenesis of scleroderma.

Authors:  S A Jiménez
Journal:  Semin Arthritis Rheum       Date:  1983-08       Impact factor: 5.532

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Role for carbohydrate structures in TGF-beta 1 latency.

Authors:  K Miyazono; C H Heldin
Journal:  Nature       Date:  1989-03-09       Impact factor: 49.962

7.  Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases.

Authors:  A J Barnett
Journal:  Med J Aust       Date:  1978-08-12       Impact factor: 7.738

8.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.

Authors:  P F Piguet; M A Collart; G E Grau; Y Kapanci; P Vassalli
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation.

Authors:  N Khalil; O Bereznay; M Sporn; A H Greenberg
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.

Authors:  A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  7 in total

1.  Transforming growth factor-β in stem cells and tissue homeostasis.

Authors:  Xin Xu; Liwei Zheng; Quan Yuan; Gehua Zhen; Janet L Crane; Xuedong Zhou; Xu Cao
Journal:  Bone Res       Date:  2018-01-31       Impact factor: 13.567

2.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice.

Authors:  A Nakao; M Fujii; R Matsumura; K Kumano; Y Saito; K Miyazono; I Iwamoto
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

3.  Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

Authors:  B Gudbjörnsson; R Hällgren; O Nettelbladt; R Gustafsson; A Mattsson; E af Geijerstam; T H Tötterman
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

4.  The control of ccn2 (ctgf) gene expression in normal and scleroderma fibroblasts.

Authors:  A Leask; S Sa; A Holmes; X Shiwen; C M Black; D J Abraham
Journal:  Mol Pathol       Date:  2001-06

5.  Transforming growth factor beta 1 gene expression in human airways.

Authors:  J D Aubert; B I Dalal; T R Bai; C R Roberts; S Hayashi; J C Hogg
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

6.  Plasma TGF beta in systemic sclerosis: a cross-sectional study.

Authors:  N Snowden; B Coupes; A Herrick; K Illingworth; M I Jayson; P E Brenchley
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

Review 7.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.